1. Driving innovation to help improve the lives of people living with cardiovascular disease

    See how we're advancing research in cardiovascular disease to address unmet needs

  2. Improving treatment options for people living with diabetes

    See how we're working to ease the burden of living with this chronic condition

  3. Leading the science behind obesity

    Learn about our commitment to driving change in how the world sees and treats obesity

  4. Learn about the safety risks of counterfeit and unapproved compounded drugs that claim to contain semaglutide

Latest news

March 30 2025

SCORE analysis of semaglutide 2.4 mg demonstrated reduction in cardiovascular events in a real-world setting

Read more

March 29 2025

Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology

Read more

March 29 2025

Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025

Read more

News archive

  1. Our pledge to you: Driving comprehensive, affordable patient access for chronic diseases

    Learn about our initiatives to support patients in need

Career opportunities

Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.

We offer 982 job opportunities